Arq, Inc. (ARQ)
NASDAQIndustrialsIndustrial - Pollution & Treatment ControlsSnapshot 2026-09-04
$2.30+1.32%
Close 2026-09-04 · 1-day change
NASDAQIndustrialsIndustrial - Pollution & Treatment ControlsSnapshot 2026-09-04
QuarterlyIQ Insights · ARQ
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Continue to grow revenue to meet the full-year 2026 guidance range of $120 to $125 million.
Stated as a priority in 3 of last 3 quarters. Revenue grew from $27.2 million in 2025-Q1 to $29.9 million in 2026-Q2, reflecting a 5% increase year-over-year in Q2. Management has consistently reaffirmed the full-year 2026 revenue guidance of $120-125 million. The trajectory shows delivering progress toward this revenue target.
“Reaffirmed full-year 2026 guidance of $120-125 million revenue”
“Reaffirmed full year 2026 guidance of revenue between $120 - $125 million”
“For fiscal year 2026, Arq expects revenue of $120-125 million.”
Maintain and improve profitability to meet the full-year 2026 Adjusted EBITDA guidance of $17 to $20 million.
Stated as a priority in 3 of last 3 quarters. Adjusted EBITDA improved from $2.7 million in 2026-Q1 to $5.8 million in 2026-Q2, showing progress toward the full-year 2026 guidance of $17-20 million. Management has consistently reaffirmed this target, indicating delivering progress on profitability.
“Reaffirmed full-year 2026 guidance of $17-20 million Adjusted EBITDA”
“Reaffirmed full year 2026 guidance of Adjusted EBITDA of $17 - $20 million”
“and Adjusted EBITDA of $17 - $20 million”
Continue the ongoing strategic optimization review including GAC facility improvements to increase furnace throughput and reduce unit costs.
Stated as a priority in 2 of last 2 quarters. The strategic optimization review remains ongoing with work to increase furnace throughput and reduce unit costs. Management expects to complete the review and have a go-forward GAC strategy by Q3 2026. The trajectory shows ongoing progress but the review is not yet complete.
“Strategic optimization review ongoing, including broader operational assessment to increase furnace throughput and reduce unit costs”
“GAC strategic optimization review ongoing with initial results expected by Q3 2026”
Develop and commercialize the PAC for PFAS™ product to address PFAS contamination and support utilities' compliance needs.
Stated as a priority in 2 of last 2 quarters. Management highlights ongoing customer testing and potential for material volume and margin contribution from 2027 onward. The trajectory shows early progress but commercialization is still in development.
“Advanced PAC for PFAS™, customer testing ongoing with potential material volume and margin contribution from 2027 onward”
“The PFAS opportunity remains compelling, early progress of PAC for PFAS™ strategy encouraging”
Pursue monetization of the Corbin Facility and related technologies to create additional optionality and funding sources.
Stated as a priority in 2 of last 2 quarters. Management reports ongoing paving tests and progress in discussions to monetize the Corbin Facility and related technologies. The trajectory shows continuing progress but no monetization milestone yet achieved.
“Continued progress towards monetizing the Corbin Facility and related technologies; paving tests ongoing”
“Progressed asphalt testing with leading U.S. asphalt company, Corbin wetcake advancing to small in-field paving tests”
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Industrials names rated weak grew net income 53% of the time over the next year (vs 58% for the rest of the cohort, n=6963).
Over the trailing year it converted 0.94x of net income into operating cash flow.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to Fed net liquidity, real (inflation-adjusted) rates, the US dollar, long-term interest rates (low R² over the window).
23 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Industrials names rated volatile grew net income 58% of the time over the next year (vs 57% for the rest of the cohort, n=2592).
Not investment advice. As of 2026-09-04.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.